Skip to content

Clostridioides difficile infection increases the need for using biologics in patients with inflammatory bowel diseases: a retrospective long-term study.

Sep 2026 · European Journal of Gastroenterology and Hepathology · 0 citations · 29 references
Medicine

TL;DR

Recognizing gastrointestinal infection promptly and integrating infection history into therapeutic decision-making may improve patient outcomes by preventing severe disease progression and guiding timely escalation of therapy.

Abstract

Background

Inflammatory bowel disease (IBD), comprising Crohn's disease and ulcerative colitis, is characterized by chronic intestinal inflammation and may be complicated by gastrointestinal infections. Among these, Clostridioides difficile infection (CDI) is relevant because of its association with worse outcomes and increased therapeutic needs. We aimed to evaluate the prevalence of enteric infections during IBD flares and to assess the long-term impact of CDI on disease management and treatment escalation.

Methods

We retrospectively analyzed 102 IBD patients hospitalized for disease flares at a single tertiary care center between January 2020 and September 2024. All patients underwent stool testing for enteric pathogens. Clinical, laboratory, and treatment data were collected at baseline and 12 months.

Results

Gastrointestinal infections were detected in 19% of patients; CDI accounted for 58% of these. At 12 months after gastrointestinal infection, advanced therapy use was more frequent in gastrointestinal infection positive (GI+) patients (63% vs. 43%; P = 0.04). CDI+ patients had a significant increase in biologic use over time. Gastrointestinal infection positivity was independently associated with biologic use at 12 months (odds ratio = 3.5, P = 0.02).

Conclusion

Recognizing gastrointestinal infection promptly and integrating infection history into therapeutic decision-making may improve patient outcomes by preventing severe disease progression and guiding timely escalation of therapy.

View source

Similar papers

Oct 2026

Clinical Profile and Outcomes of Clostridioides Difficile Infection in Noninflammatory Bowel Disease Patients: A Retrospective Study from a Tertiary Care Center.

BACKGROUND Clostridioides difficile infection (CDI) is one of the leading causes of healthcare-associated and antibiotic-associated diarrhea and is associated with significant morbidity and mortality. Data regarding the clinical characteristics and outcomes of CDI among noninflammatory bowel disease (non-IBD) patients...

Srinivas Gridhati, Sai Sarath Dasari, S. Shanmughanathan et al. · 0 citations
Review Open access Sep 2026

Current practices and unmet needs in the management of Clostridioides difficile infection in pediatric inflammatory bowel disease: A national survey.

OBJECTIVES Children with inflammatory bowel disease (IBD) are at increased risk for Clostridioides difficile infection (CDI), which is associated with worse clinical outcomes. We aimed to assess current diagnostic and therapeutic practices for CDI among Italian pediatric IBD centers. METHODS A nationwide survey was c...

A. Romanchuk, Matteo Bramuzzo, F. Labriola et al. · 0 citations
Open access Nov 2026

Colonoscopy-based Clostridioides difficile screening for inflammatory bowel disease patients.

Patients with IBD have an increased risk for Clostridioides difficile infection, and the significance of asymptomatic colonization is poorly understood. Overlapping symptoms often complicate diagnosis, and there is a lack of validated screening methods. Colonic wash aspirates collected during routine colonoscopies may...

J. Allegretti, Alexander D. Carlin, E. McClure et al. · 0 citations
Review Open access Oct 2026

Identification and Characterization of Patient Populations at High Risk for Clostridioides difficile Infection (CDI): A Narrative Review

Clostridioides difficile infection (CDI) is a major cause of infections worldwide and can lead to life-threatening complications and a severe impact on patients’ quality of life (QoL). CDI can affect anyone, but it is generally accepted that those at greatest risk include people receiving antibiotics, of older age, and...

J. Allegretti, E. Dubberke, C. Ferreira et al. · 0 citations
Open access Oct 2026

Prognostic Value of C-Reactive Protein for Intestinal Resection in Crohn’s Disease Patients with Clostridioides difficile Infection: A Single-Center Retrospective Cohort Study

Elevated CRP was associated with an increased risk of subsequent intestinal resection in CD patients with CDI and may have potential prognostic value, and these findings require prospective external validation.

Min-Hui Zheng, Xiao-Bai Pang, Li Li et al. · 0 citations
Open access Oct 2026

The Role of Aeromonas Species as Enteropathogens in Patients with Inflammatory Bowel Disease

Background/Aims Aeromonas species are Gram-negative, flagellated bacilli suggested to be associated with inflammatory bowel disease (IBD) flare-ups, but their precise role remains controversial. This retrospective study investigated Aeromonas as an enteropathogen in patients with IBD. Methods This study analyzed patien...

D. Kim, Jiyoung Yoon, Jae-Seok Kim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.